Skip to content

Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation

Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06450353
Enrollment
1200
Registered
2024-06-10
Start date
2024-05-31
Completion date
2029-06-01
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allogeneic Transplantation

Brief summary

To look at the effect of a recipient's ancestry and socio-economic status on their choice of bone marrow transplantation donor cells and their chance of receiving genetically similar (allogeneic) bone marrow cells versus cells that are not genetically similar (allograft).

Detailed description

Primary Objectives To prospectively evaluate graft options and choice of donor by patient ancestry and SES for allograft candidates at MDACC. Secondary Objectives * To prospectively evaluate time to transplant for allograft candidates at MDACC. * To evaluate treatment-related mortality for allograft candidates at MDACC. * To assess overall survival for allograft candidates at MDACC. * To prospectively evaluate receipt of preferred unrelated donor for allograft recipients at MDACC. * To evaluate receipt of an optimal graft for allograft recipients at MDACC.

Interventions

BEHAVIORALPatient Ancestry Questionnaires

Participants will be asked to complete a demographics and ancestry questionnaire at the baseline visit before you and your doctor select bone marrow donation candidates.

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. ≥ 18 years of age. 2. Candidate for allogeneic transplantation

Exclusion criteria

1\) Allogeneic stem cell transplantation not medically indicated.

Design outcomes

Primary

MeasureTime frame
Patient Ancestry QuestionnaireThrough study completion; an average of 1 year.

Countries

United States

Contacts

CONTACTWarren Fingrut, MD
wbfingrut@mdanderson.org(832) 387-8363
PRINCIPAL_INVESTIGATORWarren Fingrut, MD

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026